fda warning letter bpc-157 unapproved new drug advisers back first four of seven peptides under review for looser rules | The Mighty 790 KFGO FDA advisory committee votes to

As we age, NAD+ levels decline , leading to slower metabolism, reduced fat-burning capacity, and increased fatigue

Key Regulatory Points as of 2026: Not FDA-approved for any medical indication Cannot legally be sold as a drug, food, or dietary supplement for human consumption Legally sold as a "research chemical," not intended for human use Not a DEA-scheduled substance, so possession is not illegal (unlike anabolic steroids) Many medical clinics offer BPC-157 treatments despite lack of approval The FDA has expressed safety concerns due to the lack of human clinical trial data and the potential for adverse effects from unregulated manufacturing

Why does BPC-157's stability matter for research design

Hair that once grew thick and strong now emerges wispy and weak, if it emerges at all

Withdrawal studies were open and uncontrolled